By Hendra Lukman 
New research from a collaborative effort between the University of Surrey, the John Innes Centre, and Quadram Institute Bioscience has unveiled a potentially significant finding regarding vitamin D supplementation. The study, published in the esteemed journal Nutrition Reviews, indicates that consuming vitamin D2, a common form of supplemental vitamin D, might paradoxically lead to a decrease in the body’s levels of vitamin D3. Vitamin D3 is considered the more potent and naturally occurring form, synthesized by the skin upon exposure to sunlight and utilized most efficiently by the body to maintain adequate vitamin D status. This discovery holds considerable weight given the widespread practice of vitamin D supplementation, particularly in regions like the UK where sunlight exposure is limited for large parts of the year, and the government’s recommendation of a daily intake of 10 micrograms (µg).
Understanding Vitamin D: D2 vs. D3
The human body can acquire vitamin D through two primary routes: endogenous synthesis via ultraviolet B (UVB) radiation from sunlight and dietary intake. Supplementation has become a crucial strategy for individuals struggling to meet their vitamin D requirements through these natural channels. However, the market offers two main forms of vitamin D supplements: vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). While both are forms of vitamin D, their origins and metabolic pathways differ. Vitamin D2 is typically derived from plant sterols and fungi, whereas vitamin D3 is produced in the skin of animals, including humans, upon UVB exposure and is also found in animal-based foods like fatty fish.
For years, both forms have been used interchangeably in supplements and food fortification, with the assumption that they offer similar benefits. The recent meta-analysis, which meticulously examined data from numerous randomized controlled trials, challenges this long-held assumption. The researchers found a consistent pattern: individuals taking vitamin D2 supplements exhibited a reduction in their circulating levels of vitamin D3 compared to control groups who did not receive vitamin D2. In many instances, the observed vitamin D3 levels in the D2 supplementation groups fell below those of the control cohort, raising concerns about the overall efficacy of D2 in achieving and maintaining optimal vitamin D status.
Expert Insights and the Implication of Reduced D3
Emily Brown, PhD Research Fellow and Lead Researcher on the study from the University of Surrey’s Nutrition, Exercise, Chronobiology & Sleep Discipline, articulated the significance of these findings. "Vitamin D supplements are important, especially between October and March, when our bodies cannot make vitamin D from sunlight in the UK," she stated. "However, we discovered that vitamin D2 supplements can actually decrease levels of vitamin D3 in the body, which is a previously unknown effect of taking these supplements. This study suggests that subject to personal considerations, vitamin D3 supplements may be more beneficial for most individuals over vitamin D2."
This "previously unknown effect" is a critical takeaway. It suggests a potential competitive interaction between vitamin D2 and D3 within the body’s metabolic processes. While the exact biochemical mechanisms are still under investigation, the implication is clear: by introducing vitamin D2, individuals might inadvertently be hindering their body’s ability to utilize or maintain its stores of the more biologically active vitamin D3. This could have far-reaching consequences for public health strategies and individual supplementation choices, particularly in countries with a high prevalence of vitamin D deficiency.
Supporting Evidence and Immune Function
The findings from the University of Surrey-led meta-analysis are further bolstered by a preceding study published in Frontiers in Immunology. This earlier research, also spearheaded by Professor Colin Smith from the University of Surrey, explored the distinct roles of vitamin D2 and D3 in supporting immune function. It posited that the two forms might not be interchangeable in their impact on the immune system.
Professor Smith’s previous work suggested that vitamin D3 possesses a unique modifying effect on the immune system, potentially offering a more robust defense against viral and bacterial pathogens. Specifically, his team demonstrated that vitamin D3, but not vitamin D2, appears to stimulate the type I interferon signaling pathway. This pathway is a crucial component of the innate immune system, acting as a frontline defense mechanism against invading microorganisms. "We have shown that vitamin D3, but not vitamin D2, appears to stimulate the type I interferon signalling system in the body — a key part of the immune system that provides a first line of defence against bacteria and viruses," Professor Smith explained. "Thus, a healthy vitamin D3 status may help prevent viruses and bacteria from gaining a foothold in the body."
This convergence of evidence from two separate but related studies paints a compelling picture. Not only might vitamin D2 be less effective at raising overall vitamin D levels by potentially reducing D3, but it may also fall short in providing the same immune-boosting benefits attributed to vitamin D3. This dual concern underscores the importance of prioritizing vitamin D3 supplementation.
The Need for Accessible Plant-Based Vitamin D3
The call for greater accessibility of plant-based vitamin D3 has been amplified by these discoveries. Professor Cathie Martin, Group Leader at the John Innes Centre, commented, "This meta-analysis highlights the importance of ensuring plant-based vitamin D3 is accessible in the UK." As vitamin D3 is naturally produced in animals, the development and widespread availability of vegan and vegetarian-friendly sources of D3 are paramount to accommodate diverse dietary preferences and ethical considerations. Historically, plant-derived vitamin D2 has been the primary vegan option, but this new research suggests a re-evaluation of this approach. Innovations in producing vitamin D3 from lichen or other plant-based sources are crucial to ensure that individuals seeking to optimize their vitamin D status can do so with the most effective form, regardless of their dietary choices.
Public Health Implications and Future Directions
The ramifications of these research findings extend to broader public health initiatives. Vitamin D deficiency is a well-documented global health concern, particularly prevalent during the winter months in higher latitudes. The UK government’s recommendation of 10 µg of vitamin D daily is a testament to the recognized importance of this nutrient for bone health, immune function, and overall well-being. However, if the commonly available D2 supplements are less effective or even counterproductive in maintaining optimal D3 levels, current strategies may need revision.
Professor Martin Warren, Chief Scientific Officer at the Quadram Institute, emphasized the gravity of the situation. "Vitamin D deficiency represents a significant public health concern, especially during the winter months with significant deficiency across the UK population," he stated. "This collaborative research effort aligns well with the Quadram Institute’s mission to deliver healthier lives through food innovation to enhance the nutrient density of the food we eat. Tackling this with the most effective form of vitamin D supplementation or fortification is of the utmost importance to the health of the nation."
The research team advocates for continued investigation into the specific functionalities of vitamin D2 and D3. This further research is essential to definitively inform whether vitamin D3 should be the default, first-line choice for vitamin D supplementation, always considering individual physiological needs and medical advice. The Quadram Institute’s focus on food innovation also suggests potential avenues for enhancing the nutrient density of everyday foods through fortification with vitamin D3, offering a more integrated approach to public health.
Chronology of Research and Discovery
The journey to these conclusions has likely involved years of scientific inquiry. While the Nutrition Reviews publication is recent, it builds upon foundational knowledge of vitamin D metabolism and function. The earlier Frontiers in Immunology study, also involving Professor Smith, likely laid some of the groundwork for understanding the differential immune effects.
- Pre-2020s: Extensive research established the importance of vitamin D for bone health and identified the existence of vitamin D2 and D3. Vitamin D2 was often considered a viable alternative to D3, especially for vegetarians.
- Early 2020s (approximate): Professor Colin Smith’s research group at the University of Surrey conducts studies investigating the distinct immune system impacts of vitamin D2 and D3, culminating in the Frontiers in Immunology publication. This research highlights D3’s role in stimulating the type I interferon pathway.
- Recent Period: A collaborative meta-analysis, led by Emily Brown at the University of Surrey with input from the John Innes Centre and Quadram Institute Bioscience, is conducted. This analysis scrutinizes existing randomized controlled trials to assess the comparative effects of D2 and D3 on overall vitamin D levels.
- Publication (Current Year): The findings from the meta-analysis are published in Nutrition Reviews, revealing that vitamin D2 supplementation may decrease vitamin D3 levels. This publication is accompanied by expert commentary and calls for action.
Broader Impact and Future Recommendations
The implications of this research are multifaceted. For consumers, it necessitates a more informed approach to vitamin D supplementation. Opting for vitamin D3, particularly if derived from plant-based sources for ethical or dietary reasons, appears to be a more prudent choice based on current evidence. Healthcare professionals will need to review current supplementation guidelines and advice, potentially shifting recommendations towards D3.
For the supplement industry, this may lead to a re-evaluation of product formulations and marketing. A greater emphasis on the benefits and availability of vitamin D3 supplements, including plant-based options, could emerge. Furthermore, public health bodies may need to reconsider fortification strategies for foods and beverages, ensuring that the most effective form of vitamin D is utilized to combat deficiency.
In conclusion, this groundbreaking research from the University of Surrey, John Innes Centre, and Quadram Institute Bioscience marks a significant advancement in our understanding of vitamin D supplementation. By highlighting the potential for vitamin D2 to diminish the body’s levels of the more efficient vitamin D3, and by underscoring the distinct immune-modulating properties of D3, the study provides compelling evidence for a preferential approach to vitamin D intake. The scientific community and public health organizations are now tasked with translating these findings into actionable strategies to ensure that individuals can effectively maintain their vitamin D status for optimal health.
